BACKGROUND: The mechanisms by which Roux-en-Y gastric bypass surgery (RYGB) so effectively lowers body weight and improves glycemic control are not well understood, and murine models are essential for identifying the crucial signaling pathways involved. The aim of this study is to characterize the time course of RYGB on body weight, body composition, food intake, and energy expenditure in diet-induced obese mice and establish a tissue bank for global "omics" or targeted biochemical and structural analyses. METHODS: High-fat diet-induced obese mice were subjected to RYGB using an improved surgical technique with a small gastric pouch. The effects on body weight, body composition, food intake, and energy expenditure were compared to sham surgery, high-fat diet-restricted weight-matched controls, and never-obese chow-fed controls. RESULTS: Without mortality or complications, RYGB surgery in high-fat diet-induced obese mice gradually decreased body weight to a plateau that was more or less sustained for up to 12 weeks (33 g, -18 %, p < 0.01) and significantly lower compared with sham-operated mice (51 g, +25 %, p < 0.01), but higher (+18 %, p < 0.01) than age-matched, chow-fed control mice (27 g). Energy intake after RYGB was significantly suppressed compared to sham only for the first 10 days, but significantly higher compared to weight-matched mice. Energy expenditure after RYGB was higher throughout the study compared with weight-matched, but not sham animals. CONCLUSIONS: RYGB surgery in diet-induced obese mice results in similar body weight and body composition changes as observed in humans, but in contrast with humans, this is achieved mainly through increased energy expenditure rather than decreased food intake.
BACKGROUND: The mechanisms by which Roux-en-Y gastric bypass surgery (RYGB) so effectively lowers body weight and improves glycemic control are not well understood, and murine models are essential for identifying the crucial signaling pathways involved. The aim of this study is to characterize the time course of RYGB on body weight, body composition, food intake, and energy expenditure in diet-induced obesemice and establish a tissue bank for global "omics" or targeted biochemical and structural analyses. METHODS: High-fat diet-induced obesemice were subjected to RYGB using an improved surgical technique with a small gastric pouch. The effects on body weight, body composition, food intake, and energy expenditure were compared to sham surgery, high-fat diet-restricted weight-matched controls, and never-obese chow-fed controls. RESULTS: Without mortality or complications, RYGB surgery in high-fat diet-induced obesemice gradually decreased body weight to a plateau that was more or less sustained for up to 12 weeks (33 g, -18 %, p < 0.01) and significantly lower compared with sham-operated mice (51 g, +25 %, p < 0.01), but higher (+18 %, p < 0.01) than age-matched, chow-fed control mice (27 g). Energy intake after RYGB was significantly suppressed compared to sham only for the first 10 days, but significantly higher compared to weight-matched mice. Energy expenditure after RYGB was higher throughout the study compared with weight-matched, but not sham animals. CONCLUSIONS: RYGB surgery in diet-induced obesemice results in similar body weight and body composition changes as observed in humans, but in contrast with humans, this is achieved mainly through increased energy expenditure rather than decreased food intake.
Authors: A Laurenius; I Larsson; K J Melanson; A K Lindroos; H Lönroth; I Bosaeus; T Olbers Journal: Eur J Clin Nutr Date: 2013-01-09 Impact factor: 4.016
Authors: Adam P Chambers; Henriette Kirchner; Hilary E Wilson-Perez; Jill A Willency; John E Hale; Bruce D Gaylinn; Michael O Thorner; Paul T Pfluger; Jesus A Gutierrez; Matthias H Tschöp; Darleen A Sandoval; Randy J Seeley Journal: Gastroenterology Date: 2012-09-17 Impact factor: 22.682
Authors: James M Isbell; Robyn A Tamboli; Erik N Hansen; Jabbar Saliba; Julia P Dunn; Sharon E Phillips; Pamela A Marks-Shulman; Naji N Abumrad Journal: Diabetes Care Date: 2010-04-05 Impact factor: 19.112
Authors: J B Schmidt; S D Pedersen; N T Gregersen; L Vestergaard; M S Nielsen; C Ritz; S Madsbad; D Worm; D L Hansen; T R Clausen; J F Rehfeld; A Astrup; J J Holst; A Sjödin Journal: Int J Obes (Lond) Date: 2013-08-25 Impact factor: 5.095
Authors: Michael D Neinast; Aaron P Frank; Juliet F Zechner; Quanlin Li; Lavanya Vishvanath; Biff F Palmer; Vincent Aguirre; Rana K Gupta; Deborah J Clegg Journal: Mol Metab Date: 2015-03-03 Impact factor: 7.422
Authors: Matthew Stevenson; Ankita Srivastava; Jenny Lee; Christopher Hall; Thomas Palaia; Raymond Lau; Collin Brathwaite; Louis Ragolia Journal: Obes Surg Date: 2021-04-15 Impact factor: 4.129
Authors: Charmaine S Tam; Leanne M Redman; Frank Greenway; Karl A LeBlanc; Mark G Haussmann; Eric Ravussin Journal: J Clin Endocrinol Metab Date: 2016-08-04 Impact factor: 5.958
Authors: C Blanchard; F Moreau; A Ayer; L Toque; D Garçon; L Arnaud; F Borel; A Aguesse; M Croyal; M Krempf; X Prieur; M Neunlist; B Cariou; C Le May Journal: Int J Obes (Lond) Date: 2017-09-28 Impact factor: 5.095
Authors: Zheng Hao; R Leigh Townsend; Michael B Mumphrey; Christopher D Morrison; Heike Münzberg; Hans-Rudolf Berthoud Journal: Obes Surg Date: 2017-09 Impact factor: 4.129
Authors: Danny Ben-Zvi; Luca Meoli; Wasif M Abidi; Eirini Nestoridi; Courtney Panciotti; Erick Castillo; Palmenia Pizarro; Eleanor Shirley; William F Gourash; Christopher C Thompson; Rodrigo Munoz; Clary B Clish; Ron C Anafi; Anita P Courcoulas; Nicholas Stylopoulos Journal: Cell Metab Date: 2018-06-28 Impact factor: 27.287